Cite
Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer.
MLA
Mari, Andrea, et al. “Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer.” Urologia Internationalis, vol. 101, no. 2, Aug. 2018, pp. 197–200. EBSCOhost, https://doi.org/10.1159/000489013.
APA
Mari, A., D, A. D., Kimura, S., Resch, I., Shariat, S. F., & Klatte, T. (2018). Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer. Urologia Internationalis, 101(2), 197–200. https://doi.org/10.1159/000489013
Chicago
Mari, Andrea, Andrea, David D, Shoji Kimura, Irene Resch, Shahrokh F. Shariat, and Tobias Klatte. 2018. “Sarcopenia as a Predictive Factor for Response to Upfront Cisplatin-Based Chemotherapy in Patients with Muscle-Invasive Urothelial Bladder Cancer.” Urologia Internationalis 101 (2): 197–200. doi:10.1159/000489013.